Ch-mAb7F9

Chimeric anti-methamphetamine monoclonal antibody · InterveXion Therapeutics, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ch-mAb7F9, covering 2014-05-13 to 2014-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Ch-mAb7F9 for Methamphetamine Abuse [Phase 1]